Coronary heart disease (CHD) remains a leading cause of mortality worldwide, with conventional therapeutic strategies limited by non-specific targeting, low bioavailability, and systemic off-target effects. Nanomaterials, leveraging their unique physicochemical properties, have shown immense potential in CHD diagno...
Hui-Fang Kuang, Songyan Tie, Qi-Zhi He et al.· Frontiers in Pharmacology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.